# The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

> **NCT06033560** · — · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 6000 (estimated)

## Conditions studied

- COVID-19
- Hypoxemic Respiratory Failure

## Interventions

- **DEVICE:** High flow nasal oxygen (HFNO, more than 15 L/min)

## Key facts

- **NCT ID:** NCT06033560
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-06
- **Primary completion:** 2023-10
- **Final completion:** 2023-11
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06033560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06033560, "The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06033560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*